Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
about
Microtubule-Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer ChemotherapyStathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerβIII-Tubulin: biomarker of taxane resistance or drug target?Microtubules and their role in cellular stress in cancerMammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.RETRACTED: STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells.P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxaneExpression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma.Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer.Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancerStathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma.Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo.Stathmin: a protein with many tasks. New biomarker and potential target in cancer.High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma.An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy ResistanceOverexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer.STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer.Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells.
P2860
Q26786510-F5C34038-EC65-4983-991A-45D49FA54907Q27852937-1D512F74-1D6D-4AEA-B2D1-425052634C59Q28284878-693AEE37-73B7-4EAB-9257-63E71253D36DQ33770927-9658393A-A293-4FCC-B565-2D8F7CAB45BBQ34664059-1FE20EB3-F702-4E57-8970-F8F176ACBEABQ35085500-BA2FDAAF-FF7F-4673-8236-2494E8DBAA61Q35376227-30BBC5B1-C064-4C02-83DC-C413DC53C6B2Q36642789-A0098622-391F-4D22-B02E-8ABB7B6A6D23Q36756699-0BED9BA4-8551-4333-8479-C1AD565C796AQ36774388-61354E6C-2E01-4CC0-BEF1-E218C26A8423Q36931508-533CAD26-71D1-4AFA-B77B-E52274924729Q37359873-7E141623-1C45-4759-8FA5-55250C68D990Q37942978-4EA620D0-2ED0-45F8-807F-B0B38E5AADCAQ38770214-FF308534-2AFD-425D-A6A8-6F15F0088CF9Q38847914-606C341A-527A-4CF5-AE49-2CECB34C6B80Q38882319-386339AE-D6E8-47C3-9247-8B6D2AB67905Q39005616-0E0640CD-E4AE-44B8-B8AB-0E6117B93FF7Q39064242-655F91F6-60F6-4736-8C10-1A73920D2FB5Q39414846-DAB17AEA-46F0-4E2C-9AAB-34F0B1A947E9Q46284216-A0F2FE54-35E9-4F53-B438-F9172A4CB437Q46373414-EF4CD957-9059-4952-B459-6E3312C8F290Q50678236-CA054D45-31E0-4F18-A997-14316031AACAQ53536522-2684F984-F062-4A1B-BBBA-63671F135F75Q55085143-D0FA67AE-246D-45F9-87C1-0D4AF7CC7B86Q55427270-B577ADE4-0D37-49C4-84D0-CEAF8BCA2CB8
P2860
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Stathmin and tubulin expressio ...... t with and without paclitaxel.
@en
Stathmin and tubulin expressio ...... t with and without paclitaxel.
@nl
type
label
Stathmin and tubulin expressio ...... t with and without paclitaxel.
@en
Stathmin and tubulin expressio ...... t with and without paclitaxel.
@nl
prefLabel
Stathmin and tubulin expressio ...... t with and without paclitaxel.
@en
Stathmin and tubulin expressio ...... t with and without paclitaxel.
@nl
P2093
P50
P356
P1433
P1476
Stathmin and tubulin expressio ...... nt with and without paclitaxel
@en
P2093
Dionyssios Katsaros
Herbert Yu
Peter Schwartz
Saverio Danese
Shenglin Ma
Thomas J Rutherford
P304
P356
10.1002/CNCR.24282
P407
P577
2009-06-01T00:00:00Z